In Japan, regenerative medicine is provided within applicable legal and regulatory frameworks, including required notification, review, and management systems as relevant to the treatment. For needs such as stem cell therapy, immune cell therapy, chronic pain, age-related care, and functional recovery support after illness, we organize the relevant information and coordinate preliminary confirmation of feasibility and eligibility with the medical institution based on the treatment objective and the individual’s health status.
Key Features: Regenerative medicine is not a uniform treatment suitable for everyone. After reviewing medical history, current health status, test results, and treatment objectives, we organize information on potential medical institutions, treatment plans, risk explanations, fees, and travel schedules, and support care coordination. Treatment eligibility, medical appropriateness, and safety are determined and explained by the treating physician and medical institution.
